RedHill Biopharma Ltd.
5.41
-0.19 (-3.39%)
At close: Jan 14, 2025, 3:58 PM
5.51
1.77%
After-hours Jan 14, 2025, 03:59 PM EST
undefined%
Bid 5.3
Market Cap 6.90M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -302.63
PE Ratio (ttm) -0.02
Forward PE n/a
Analyst n/a
Ask 5.7
Volume 8,745
Avg. Volume (20D) 16,673
Open 5.75
Previous Close 5.60
Day's Range 5.41 - 5.75
52-Week Range 5.41 - 31.50
Beta undefined

About RDHL

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development pr...

Sector Healthcare
IPO Date Jan 7, 2013
Employees 53
Stock Exchange NASDAQ
Ticker Symbol RDHL
4 months ago · Source
+25.06%
Redhill Biopharma shares are trading higher after ... Unlock content with Pro Subscription
4 months ago · Source
+10.76%
Redhill Biopharma shares are trading higher after the company announced results from multiple in vivo studies.